Over 10,000 results
Page 8 of 100
C-TR
ivxi1dkesisrvjg
19 Apr 24
Termination of reporting (crowdfunding)
5:17pm
424B2
oajj5zfudtyxj21u0i7m
19 Apr 24
Prospectus for primary offering
5:17pm
424B2
zv9 hab3vkt70em3gb
19 Apr 24
Prospectus for primary offering
5:17pm
424B2
gga86lwjfm2l oui0hy
19 Apr 24
Prospectus for primary offering
5:17pm
424B2
ne1ih0r2q7m
19 Apr 24
Prospectus for primary offering
5:17pm
6-K
buvl fb2pse
19 Apr 24
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
5:17pm
424B2
ic4eguh ll3
19 Apr 24
Prospectus for primary offering
5:17pm
424B2
5i152o9j mm
19 Apr 24
Prospectus for primary offering
5:17pm
ARS
hndgajvztnob
19 Apr 24
Annual report to shareholders
5:17pm
424B2
vjrnj ozdpfgr
19 Apr 24
Prospectus for primary offering
5:17pm
8-K
lg0y55bmu6
19 Apr 24
Xcel Brands, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results
5:16pm
424B2
lq9l7vglz
19 Apr 24
Prospectus for primary offering
5:16pm
424B2
x1i8e15nbg59fb8if7
19 Apr 24
Prospectus for primary offering
5:16pm
D
lmovp1qn03a gnar
19 Apr 24
$4.50 mm in equity, sold $4.50 mm, 10 investors
5:16pm
6-K
3wmkeuap6r5tg8i
19 Apr 24
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
5:16pm
8-K/A
6ozizbaua
19 Apr 24
Huntington Bancshares Incorporated Reports 2024 First-quarter Earnings
5:15pm
8-K
sni73u
19 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
ks19gjqh2fet dxp
19 Apr 24
Regulation FD Disclosure
5:15pm
424B2
ovxsp 54yonkq5o89l1
19 Apr 24
Prospectus for primary offering
5:15pm
8-K
tajryhvzcwg
19 Apr 24
Departure of Directors or Certain Officers
5:15pm